70 related articles for article (PubMed ID: 35077445)
1. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin GW; Xu C; Chen K; Huang HQ; Chen J; Song B; Chan JKC; Li W; Liu W; Shih LY; Chuang WY; Kim WS; Tan W; Peng RJ; Laurensia Y; Cheah DMZ; Huang D; Cheng CL; Su YJ; Tan SY; Ng SB; Tang TPL; Han K; Wang VY; Jia WH; Pei Z; Li YJ; Gao S; Shi Y; Hu Z; Zhang F; Zhang B; Zeng YX; Shen H; He L; Ong CK; Lim ST; Chanock S; Kwong YL; Lin D; Rothman N; Khor CC; Lan Q; Bei JX;
Lancet Oncol; 2020 Feb; 21(2):306-316. PubMed ID: 31879220
[TBL] [Abstract][Full Text] [Related]
2. A novel ZAP-70 dependent FRET based biosensor reveals kinase activity at both the immunological synapse and the antisynapse.
Randriamampita C; Mouchacca P; Malissen B; Marguet D; Trautmann A; Lellouch AC
PLoS One; 2008 Jan; 3(1):e1521. PubMed ID: 18231606
[TBL] [Abstract][Full Text] [Related]
3. T-cell dysfunction in natural killer/T-cell lymphoma.
Feng X; Meng M; Li H; Gao Y; Song W; Di R; Li Z; Zhang X; Zhang M
Oncoimmunology; 2023; 12(1):2212532. PubMed ID: 37250921
[TBL] [Abstract][Full Text] [Related]
4. ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies.
Chen J; Moore A; Ringshausen I
Front Oncol; 2020; 10():595832. PubMed ID: 33194762
[TBL] [Abstract][Full Text] [Related]
5. High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Garcha HK; Nawar N; Sorger H; Erdogan F; Aung MMK; Sedighi A; Manaswiyoungkul P; Seo HS; Schönefeldt S; Pölöske D; Dhe-Paganon S; Neubauer HA; Mustjoki SM; Herling M; de Araujo ED; Moriggl R; Gunning PT
Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355493
[TBL] [Abstract][Full Text] [Related]
6. Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS).
Zhu L; Xie S; Yang C; Hua N; Wu Y; Wang L; Ni W; Tong X; Fei M; Wang S
Cancer Manag Res; 2021; 13():5275-5286. PubMed ID: 34239326
[TBL] [Abstract][Full Text] [Related]
7. Molecular underpinning of extranodal NK/T-cell lymphoma.
Huang Y; de Leval L; Gaulard P
Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
[TBL] [Abstract][Full Text] [Related]
8. T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
de Mel S; Mustafa N; Selvarajan V; Azaman MI; Jaynes PW; Venguidessane S; Phuong HM; Alnaseri ZT; Phyu T; Girard LP; Chng WJ; Wardyn J; Li Y; An O; Yang H; Ng SB; Jeyasekharan AD
PLoS One; 2022; 17(1):e0261469. PubMed ID: 35077445
[TBL] [Abstract][Full Text] [Related]
9. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
11. Control of TCR-mediated activation of beta 1 integrins by the ZAP-70 tyrosine kinase interdomain B region and the linker for activation of T cells adapter protein.
Goda S; Quale AC; Woods ML; Felthauser A; Shimizu Y
J Immunol; 2004 May; 172(9):5379-87. PubMed ID: 15100278
[TBL] [Abstract][Full Text] [Related]
12. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
13. IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma.
Wang L; Bi XW; Zhu YJ; He YZ; Lai QY; Xia ZJ; Cai QQ
Cancer Commun (Lond); 2018 Oct; 38(1):62. PubMed ID: 30340635
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
